Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
872 INR | -3.06% | -0.02% | +34.32% |
11:20am | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
May. 22 | Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.32% | 993M | |
+17.79% | 22.02B | |
+18.96% | 15.08B | |
+19.33% | 14.37B | |
+57.60% | 13.06B | |
-9.70% | 6.75B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.66% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science ChairTakes Over CEO Role